- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Lithium chloride improves radiation-induced oral mucositis and taste dysfunction: Study
Alexandria, Va., USA - Oral mucositis and taste dysfunction (dysgeusia) occurs in nearly all patients receiving head and neck radiotherapy and tremendously affects the quality of life and treatment outcome. The study "LiCl Promotes Recovery of Radiation-Induced Oral Mucositis and Dysgeusia" published in the Journal of Dental Research (JDR), investigated the hypothesis that lithium chloride (LiCl) can promote the restoration of oral mucosa integrity and taste function after radiation.
LiCl is a potent activator of a key cell signaling pathway called Wnt/β-catenin that is critical for the development, regeneration and function of many tissue types. Researchers at the West China Hospital of Stomatology, Sichuan University, Chengdu, China, the University of Illinois at Chicago, USA, and the Clinical Research Center for Oral Diseases of Sichuan Province, Chengdu, China, compared the treatment efficacy of LiCl on oral mucositis to the treatment efficacy using keratinocyte growth factor, an agent approved by the U.S. Food and Drug Administration for oral mucositis.
The results showed that LiCl alleviated the weight loss and tongue ulceration of the mice with radiation-induced oral mucositis, as well promoted proliferation of basal epithelial cells and inhibited epithelial-mesenchymal transition in tongue mucosa. The mice treated with LiCl showed an elevated taste bud renewal and taste-distortion recovery toward sweetness as compared to the mice treated using keratinocyte growth factor.
"The data from this study demonstrate that LiCl can mitigate radiation-induced oral mucositis by promoting cell proliferation in the basal layer and inhibiting epithelial-mesenchymal transition of the oral mucosa," said JDR Editor-in-Chief Nicholas Jakubovics, Newcastle University, England. "Lithium has been used in clinical practice for decades and is currently recommended as a first-line therapy for bipolar disorder. It is exciting to see that LiCl may also represent a promising new therapy to improve the quality of life of patients receiving radiotherapy."
https://journals.sagepub.com/doi/10.1177/0022034521997112
Hina Zahid Joined Medical Dialogue in 2017 with a passion to work as a Reporter. She coordinates with various national and international journals and association and covers all the stories related to Medical guidelines, Medical Journals, rare medical surgeries as well as all the updates in the medical field. Email:Â editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751